6/2
06:26 pm
npce
How The NeuroPace (NPCE) Investment Story Is Shifting Without A New Analyst Price Target [Yahoo! Finance]
Low
Report
How The NeuroPace (NPCE) Investment Story Is Shifting Without A New Analyst Price Target [Yahoo! Finance]
5/29
08:43 am
npce
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care [Yahoo! Finance]
Medium
Report
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care [Yahoo! Finance]
5/29
08:43 am
npce
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting [Yahoo! Finance]
Medium
Report
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting [Yahoo! Finance]
5/29
08:05 am
npce
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
Medium
Report
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
5/29
08:00 am
npce
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
High
Report
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
5/27
08:11 pm
npce
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift? [Yahoo! Finance]
Low
Report
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift? [Yahoo! Finance]
5/27
01:37 pm
npce
NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care [Yahoo! Finance]
Low
Report
NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care [Yahoo! Finance]
5/15
01:35 pm
npce
NeuroPace (NPCE) had its price target raised by HC Wainwright from $19.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
NeuroPace (NPCE) had its price target raised by HC Wainwright from $19.00 to $20.00. They now have a "buy" rating on the stock.
5/14
03:38 pm
npce
NeuroPace (NPCE) Q1 2026 Earnings Transcript [Yahoo! Finance]
Low
Report
NeuroPace (NPCE) Q1 2026 Earnings Transcript [Yahoo! Finance]
5/14
03:03 pm
npce
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]
Low
Report
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]
5/13
01:16 am
npce
NeuroPace Inc (NPCE) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... [Yahoo! Finance]
Low
Report
NeuroPace Inc (NPCE) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... [Yahoo! Finance]
5/12
10:12 pm
npce
Neuropace signals $99M-$101M 2026 revenue outlook while targeting 21%-23% underlying RNS growth [Seeking Alpha]
Low
Report
Neuropace signals $99M-$101M 2026 revenue outlook while targeting 21%-23% underlying RNS growth [Seeking Alpha]
5/12
10:12 pm
npce
NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript [Seeking Alpha]
Low
Report
NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript [Seeking Alpha]
5/12
09:36 pm
npce
NeuroPace Q1 Earnings Call Highlights [Yahoo! Finance]
Low
Report
NeuroPace Q1 Earnings Call Highlights [Yahoo! Finance]
5/12
04:05 pm
npce
NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
Low
Report
NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
5/11
12:43 pm
npce
NeuroPace Inc (NPCE) Q1 2026 Earnings Report Preview: What To Expect [Yahoo! Finance]
Medium
Report
NeuroPace Inc (NPCE) Q1 2026 Earnings Report Preview: What To Expect [Yahoo! Finance]
4/29
04:05 pm
npce
NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026
Low
Report
NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026
4/27
09:03 am
npce
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026 [Yahoo! Finance]
Low
Report
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026 [Yahoo! Finance]
4/27
07:30 am
npce
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026
Low
Report
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026
4/10
04:05 pm
npce
NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference
Medium
Report
NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference
4/1
12:39 pm
npce
How Shifting Margin Assumptions Are Rewriting The NeuroPace (NPCE) Investment Narrative [Yahoo! Finance]
Low
Report
How Shifting Margin Assumptions Are Rewriting The NeuroPace (NPCE) Investment Narrative [Yahoo! Finance]
3/19
06:20 am
npce
NeuroPace (NPCE) was upgraded by Wells Fargo & Company to "strong-buy".
Medium
Report
NeuroPace (NPCE) was upgraded by Wells Fargo & Company to "strong-buy".
3/18
10:32 am
npce
How The NeuroPace (NPCE) Story Is Shifting As Analysts Refresh Valuation Assumptions [Yahoo! Finance]
Low
Report
How The NeuroPace (NPCE) Story Is Shifting As Analysts Refresh Valuation Assumptions [Yahoo! Finance]
3/15
01:05 am
npce
Low
Report